• Leadership team aligned with shareholders, successfully implementing a strategy to transform the business
  • Building a comprehensive, fully integrated suite of preclinical solutions, ranging from small / large molecule therapies to medical devices and research models
  • Delivering superior client experiences (client-centric focus)
  • Driving value and growth through acquisitions and internal investments
  • Significant operating leverage and margin expansion potential with increasing revenues
  • Benefiting from favorable industry tailwinds and participation in premium growth segments, such as emerging biopharma